Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
TAK reports speaker honoraria and an advisory board role for Exact Sciences and is on the global advisory board of Besins Healthcare. ELM reports consulting for Lilly, Novartis, AstraZeneca, Gilead, and Diaccurate. MCM reports consulting for Exact Sciences, Pfizer, Roche, Astra Zeneca, Lilly, Novartis, and Abbott; and research support from Novartis and Pfizer. LAN reports research support from Genentech. EAM reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speakers’ honoraria and travel support from Merck Sharp & Dohme; and institutioal research support from Roche/Genentech (via SU2C grant) and Gilead. EAM also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kantor, O., King, T.A., Jones, A. et al. ASO Visual Abstract: Racial and Ethnic Disparities in Outcomes after Breast-Conserving Therapy and Endocrine Therapy for DCIS—A Post Hoc Analysis of the NSABP B-35 Randomized, Clinical Trial. Ann Surg Oncol 31, 1010–1011 (2024). https://doi.org/10.1245/s10434-023-14493-1
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14493-1